Compare IHRT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IHRT | NPCE |
|---|---|---|
| Founded | 1974 | 1997 |
| Country | United States | United States |
| Employees | 9550 | N/A |
| Industry | Broadcasting | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.7M | 432.3M |
| IPO Year | N/A | 2021 |
| Metric | IHRT | NPCE |
|---|---|---|
| Price | $3.77 | $15.45 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $4.25 | ★ $18.33 |
| AVG Volume (30 Days) | ★ 541.5K | 165.9K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | $9.96 | $0.90 |
| Revenue Next Year | N/A | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $0.95 | $7.56 |
| 52 Week High | $5.44 | $18.97 |
| Indicator | IHRT | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 66.12 | 62.07 |
| Support Level | $3.62 | $15.25 |
| Resistance Level | $4.00 | $15.71 |
| Average True Range (ATR) | 0.18 | 0.67 |
| MACD | 0.10 | 0.22 |
| Stochastic Oscillator | 80.16 | 91.26 |
iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.